Clinical Trial

Autologous Platelet-rich Plasma Versus Whole Blood for Epidural Patch in Spontaneous Intracranial Hypotension

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Spontaneous intracranial hypotension (SIH) is a condition characterized by refractory orthostatic headache, mostly due to leaks of cerebrospinal fluid (CSF). Epidural patch with autologous platelet-rich plasma (PRP), which contains numerous growth factors and cytokines, has been reported as a new and promising alternative for current standard whole blood patching. However, there is no study comparing the efficacy and safety of the two approaches. In this study, we aimed to provide data concerning the outcomes of PRP patching versus conventional whole blood patching for treatment of refractory SIH cases failing in conservative therapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-16.
Trial Details
NCT Number NCT07602556
Lead Sponsor Beijing Tiantan Hospital
Conditions Spontaneous Intracranial Hypotension
Enrollment 218 participants
Start Date 2026-05
Primary Completion 2028-12 (estimated)
Study Completion 2029-03 (estimated)
Updated on ClinicalTrials.gov 2026-05-27